Although some of the technology in this area is definitely in its infancy still, the financial feasibility of this approach to reduce the risk of developing the metabolic syndrome provides been explored by economists within the Lipgene project.’ Results of his research will also be offered at the workshop. Foods with an modified fatty acid composition have the potential to play an invaluable role in the battle against the rising tide of the metabolic syndrome, type 2 diabetes and cardiovascular disease, without consumers having to make major changes with their dietary habits. The buyer acceptability of this approach is being regarded at the workshop also, and has been explored in detail as part of the Lipgene project..But the price detailed at Drugstore.com suggests it’s not cheap, with a two-week supply of the dosage used in the analysis costing $910, or around $21 a pill. As the response to rifaximin may seem low to outsiders, it’s in the range seen with various other effective IBS treatments, stated Dr. Jan Tack of the University of Leuven in Belgium. Additional findings suggest that a larger number of sufferers may experienced some benefit – not to the amount of ‘adequate alleviation’ that was used in these research to measure response, he stated.